375 related articles for article (PubMed ID: 16080087)
21. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
Zheng F; Zha H; Yang D; Deng J; Zhang Z
Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
[TBL] [Abstract][Full Text] [Related]
23. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
24. Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies--high frequency of false-positive results and their analysis.
Racil Z; Kocmanova I; Lengerova M; Weinbergerova B; Buresova L; Toskova M; Winterova J; Timilsina S; Rodriguez I; Mayer J
J Med Microbiol; 2010 Sep; 59(Pt 9):1016-1022. PubMed ID: 20488937
[TBL] [Abstract][Full Text] [Related]
25. How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.
Hammarström H; Kondori N; Friman V; Wennerås C
Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):917-25. PubMed ID: 25573536
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
[TBL] [Abstract][Full Text] [Related]
27. Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections.
Bellanger AP; Grenouillet F; Henon T; Skana F; Legrand F; Deconinck E; Millon L
APMIS; 2011 Apr; 119(4-5):280-6. PubMed ID: 21492228
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study.
Engsbro AL; Najat S; Jørgensen KM; Kurtzhals JAL; Arendrup MC
Med Mycol; 2019 Aug; 57(6):710-717. PubMed ID: 30535059
[TBL] [Abstract][Full Text] [Related]
29. [The effect of albumin on (1, 3)-β-D-glucan for diagnosis of invasive fungal infections].
Han S; Su X; Zhao R; Fang K
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):672-6. PubMed ID: 26255017
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.
Reischies FM; Prattes J; Woelfler A; Eigl S; Hoenigl M
Transpl Infect Dis; 2016 Jun; 18(3):466-70. PubMed ID: 26992092
[TBL] [Abstract][Full Text] [Related]
31. Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.
Lo Cascio G; Koncan R; Stringari G; Russo A; Azzini A; Ugolini A; Ligozzi M; Polati E; Cornaglia G; Concia E; Schweiger V
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):357-65. PubMed ID: 25217227
[TBL] [Abstract][Full Text] [Related]
32. (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.
Jaijakul S; Vazquez JA; Swanson RN; Ostrosky-Zeichner L
Clin Infect Dis; 2012 Aug; 55(4):521-6. PubMed ID: 22573851
[TBL] [Abstract][Full Text] [Related]
33. Bronchoalveolar Lavage Fluid (1,3)β-D-Glucan for the Diagnosis of Invasive Fungal Infections in Solid Organ Transplantation: A Prospective Multicenter Study.
Mutschlechner W; Risslegger B; Willinger B; Hoenigl M; Bucher B; Eschertzhuber S; Lass-Flörl C
Transplantation; 2015 Sep; 99(9):e140-4. PubMed ID: 25710608
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis.
Lu Y; Chen YQ; Guo YL; Qin SM; Wu C; Wang K
Intern Med; 2011; 50(22):2783-91. PubMed ID: 22082890
[TBL] [Abstract][Full Text] [Related]
35. Serum and bal beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients.
Salerno D; Mushatt D; Myers L; Zhuang Y; de la Rua N; Calderon EJ; Welsh DA
Respir Med; 2014 Nov; 108(11):1688-95. PubMed ID: 25448310
[TBL] [Abstract][Full Text] [Related]
36. Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
Koo S; Baden LR; Marty FM
Clin Microbiol Infect; 2012 May; 18(5):E122-7. PubMed ID: 22404638
[TBL] [Abstract][Full Text] [Related]
37. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
[TBL] [Abstract][Full Text] [Related]
38. Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants.
Zhao D; Qiu G; Luo Z; Zhang Y
PLoS One; 2015; 10(4):e0123907. PubMed ID: 25874376
[TBL] [Abstract][Full Text] [Related]
39. Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.
Presterl E; Parschalk B; Bauer E; Lassnigg A; Hajdu S; Graninger W
Int J Infect Dis; 2009 Nov; 13(6):707-12. PubMed ID: 19157947
[TBL] [Abstract][Full Text] [Related]
40. Preemptive treatment of fungal infection based on plasma (1 --> 3)beta-D-glucan levels after liver transplantation.
Akamatsu N; Sugawara Y; Kaneko J; Tamura S; Makuuchi M
Infection; 2007 Oct; 35(5):346-51. PubMed ID: 17885729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
